Tags: Drug.

Dapagliflozin (INN/USAN trade name Farxiga in the US and Forxiga in the EU) is a drug used to treat type 2 diabetes. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca.

Dapagliflozin_structure.svg
ATC prefix
A10
ATC suffix
BX09
CAS number
461432-26-8
FDA UNII code
1ULL0QJ8UC
IUPAC name
(2S3R4R5S6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-345-triol
PubChem
9887712

Loading...

This page contains content from the copyrighted Wikipedia article "Dapagliflozin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.